Concord Medical Services Holdings Limited (CCM)
NYSE: CCM · Real-Time Price · USD
4.300
-0.350 (-7.53%)
Nov 17, 2025, 4:00 PM EST - Market closed
CCM Revenue
Concord Medical Services Holdings had revenue of 200.62M CNY in the half year ending June 30, 2025, a decrease of -29.49%. This brings the company's revenue in the last twelve months to 365.76M, down -22.46% year-over-year. In the year 2024, Concord Medical Services Holdings had annual revenue of 383.96M, down -28.55%.
Revenue (ttm)
365.76M CNY
Revenue Growth
-22.46%
P/S Ratio
0.37
Revenue / Employee
614,724 CNY
Employees
595
Market Cap
18.67M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 383.96M | -153.45M | -28.55% |
| Dec 31, 2023 | 537.40M | 65.32M | 13.84% |
| Dec 31, 2022 | 472.09M | -13.55M | -2.79% |
| Dec 31, 2021 | 485.63M | 262.62M | 117.76% |
| Dec 31, 2020 | 223.01M | 24.65M | 12.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CCM News
- 4 weeks ago - Top 2 Health Care Stocks That May Keep You Up At Night This Month - Benzinga
- 7 weeks ago - Concord Medical Reports Financial Results for the First Half of 2025 - PRNewsWire
- 4 months ago - Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma - PRNewsWire
- 6 months ago - Concord Healthcare Announces Official Release of the Proton Therapy Large Model - PRNewsWire
- 7 months ago - Concord Medical Files Annual Report on Form 20-F for Fiscal 2024 - PRNewsWire
- 11 months ago - Concord Medical Announces Result of 2024 Annual General Meeting - PRNewsWire
- 1 year ago - Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate - PRNewsWire
- 1 year ago - Concord Medical Schedules 2024 Annual Meeting of Shareholders - PRNewsWire